A multicenter phase 3 trial comparing ocrelizumab to fingolimod for children with MS achieved its noninferiority primary ...

A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective ...

Germany is the first European country to launch the product, with further rollouts across Europe to followThe next-generation ...

Topline trial data showed that a higher Ocrevus dose didn't provide more benefit than the standard regimen in people with ...

Vidofludimus calcium reduced the risk of confirmed disability worsening in people with progressive and relapsing forms of MS, ...

Having inactive secondary progressive multiple sclerosis can be confusing. Relapses may stop, but symptoms persist. Get ...

Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

The 51-mile Multiple Steps for Multiple Sclerosis (MS4MS) walk, led by Jessica Fincham from north Hampshire, raised £58,000 for the MS Society’s Stop MS Appeal. Jessica said: "It has been an ...

Jessica Fincham, 50, from North Hampshire, finished the walk on September 21, raising £58,000 for the MS Society through her "Multiple ...

In a large PPMS population that included older patients and people with more advanced disease, ocrelizumab led to a 30% risk ...

From Olympic cyclists to multiple sclerosis sufferers, the stories behind those taking part in the Cardiff Half Marathon 2025 ...